IFCC working group recommendations for assessing commutability part 1: General experimental design

W. Greg Miller, Heinz Schimmel, Robert Rej, Neil Greenberg, Ferruccio Ceriotti, Chris Burns, Jeffrey R. Budd, Cas Weykamp, Vincent Delatour, Göran Nilsson, Finlay MacKenzie, Mauro Panteghini, Thomas Keller, Johanna E. Camara, Ingrid Zegers, Hubert W. Vesper

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Commutability is a property of a reference material (RM) that relates to the closeness of agreement between results for an RM and results for clinical samples (CSs) when measured by 2 measurement procedures (MPs). Commutability of RMs used in a calibration traceability scheme is an essential property for them to be fit for purpose. Similarly, commutability of trueness controls or external quality assessment samples is essential when those materials are used to assess trueness of results for CSs. This report is part 1 of a 3-part series describing how to assess commutability of RMs. Part 1 defines commutability and addresses critical components of the experimental design for commutability assessment, including selection of individual CSs, use of pooled CSs, qualification of MPs for inclusion, establishing criteria for the determination that an RM is commutable, generalization of commutability conclusions to future measurements made with the MPs included in the assessment, and information regarding commutability to be included in the certificate for an RM. Parts 2 and 3 in the series present 2 different statistical approaches to commutability assessment that use fixed criteria related to the medical decisions that will be made using the laboratory test results.

Original languageEnglish
Pages (from-to)447-454
Number of pages8
JournalClinical Chemistry
Volume64
Issue number3
DOIs
Publication statusPublished - Mar 1 2018

Fingerprint

Design of experiments
Research Design
Calibration

ASJC Scopus subject areas

  • Clinical Biochemistry
  • Biochemistry, medical

Cite this

IFCC working group recommendations for assessing commutability part 1 : General experimental design. / Miller, W. Greg; Schimmel, Heinz; Rej, Robert; Greenberg, Neil; Ceriotti, Ferruccio; Burns, Chris; Budd, Jeffrey R.; Weykamp, Cas; Delatour, Vincent; Nilsson, Göran; MacKenzie, Finlay; Panteghini, Mauro; Keller, Thomas; Camara, Johanna E.; Zegers, Ingrid; Vesper, Hubert W.

In: Clinical Chemistry, Vol. 64, No. 3, 01.03.2018, p. 447-454.

Research output: Contribution to journalArticle

Miller, WG, Schimmel, H, Rej, R, Greenberg, N, Ceriotti, F, Burns, C, Budd, JR, Weykamp, C, Delatour, V, Nilsson, G, MacKenzie, F, Panteghini, M, Keller, T, Camara, JE, Zegers, I & Vesper, HW 2018, 'IFCC working group recommendations for assessing commutability part 1: General experimental design', Clinical Chemistry, vol. 64, no. 3, pp. 447-454. https://doi.org/10.1373/clinchem.2017.277525
Miller, W. Greg ; Schimmel, Heinz ; Rej, Robert ; Greenberg, Neil ; Ceriotti, Ferruccio ; Burns, Chris ; Budd, Jeffrey R. ; Weykamp, Cas ; Delatour, Vincent ; Nilsson, Göran ; MacKenzie, Finlay ; Panteghini, Mauro ; Keller, Thomas ; Camara, Johanna E. ; Zegers, Ingrid ; Vesper, Hubert W. / IFCC working group recommendations for assessing commutability part 1 : General experimental design. In: Clinical Chemistry. 2018 ; Vol. 64, No. 3. pp. 447-454.
@article{ea945ee3874e49938bbcc297cfc1fadf,
title = "IFCC working group recommendations for assessing commutability part 1: General experimental design",
abstract = "Commutability is a property of a reference material (RM) that relates to the closeness of agreement between results for an RM and results for clinical samples (CSs) when measured by 2 measurement procedures (MPs). Commutability of RMs used in a calibration traceability scheme is an essential property for them to be fit for purpose. Similarly, commutability of trueness controls or external quality assessment samples is essential when those materials are used to assess trueness of results for CSs. This report is part 1 of a 3-part series describing how to assess commutability of RMs. Part 1 defines commutability and addresses critical components of the experimental design for commutability assessment, including selection of individual CSs, use of pooled CSs, qualification of MPs for inclusion, establishing criteria for the determination that an RM is commutable, generalization of commutability conclusions to future measurements made with the MPs included in the assessment, and information regarding commutability to be included in the certificate for an RM. Parts 2 and 3 in the series present 2 different statistical approaches to commutability assessment that use fixed criteria related to the medical decisions that will be made using the laboratory test results.",
author = "Miller, {W. Greg} and Heinz Schimmel and Robert Rej and Neil Greenberg and Ferruccio Ceriotti and Chris Burns and Budd, {Jeffrey R.} and Cas Weykamp and Vincent Delatour and G{\"o}ran Nilsson and Finlay MacKenzie and Mauro Panteghini and Thomas Keller and Camara, {Johanna E.} and Ingrid Zegers and Vesper, {Hubert W.}",
year = "2018",
month = "3",
day = "1",
doi = "10.1373/clinchem.2017.277525",
language = "English",
volume = "64",
pages = "447--454",
journal = "Clinical Chemistry",
issn = "0009-9147",
publisher = "American Association for Clinical Chemistry Inc.",
number = "3",

}

TY - JOUR

T1 - IFCC working group recommendations for assessing commutability part 1

T2 - General experimental design

AU - Miller, W. Greg

AU - Schimmel, Heinz

AU - Rej, Robert

AU - Greenberg, Neil

AU - Ceriotti, Ferruccio

AU - Burns, Chris

AU - Budd, Jeffrey R.

AU - Weykamp, Cas

AU - Delatour, Vincent

AU - Nilsson, Göran

AU - MacKenzie, Finlay

AU - Panteghini, Mauro

AU - Keller, Thomas

AU - Camara, Johanna E.

AU - Zegers, Ingrid

AU - Vesper, Hubert W.

PY - 2018/3/1

Y1 - 2018/3/1

N2 - Commutability is a property of a reference material (RM) that relates to the closeness of agreement between results for an RM and results for clinical samples (CSs) when measured by 2 measurement procedures (MPs). Commutability of RMs used in a calibration traceability scheme is an essential property for them to be fit for purpose. Similarly, commutability of trueness controls or external quality assessment samples is essential when those materials are used to assess trueness of results for CSs. This report is part 1 of a 3-part series describing how to assess commutability of RMs. Part 1 defines commutability and addresses critical components of the experimental design for commutability assessment, including selection of individual CSs, use of pooled CSs, qualification of MPs for inclusion, establishing criteria for the determination that an RM is commutable, generalization of commutability conclusions to future measurements made with the MPs included in the assessment, and information regarding commutability to be included in the certificate for an RM. Parts 2 and 3 in the series present 2 different statistical approaches to commutability assessment that use fixed criteria related to the medical decisions that will be made using the laboratory test results.

AB - Commutability is a property of a reference material (RM) that relates to the closeness of agreement between results for an RM and results for clinical samples (CSs) when measured by 2 measurement procedures (MPs). Commutability of RMs used in a calibration traceability scheme is an essential property for them to be fit for purpose. Similarly, commutability of trueness controls or external quality assessment samples is essential when those materials are used to assess trueness of results for CSs. This report is part 1 of a 3-part series describing how to assess commutability of RMs. Part 1 defines commutability and addresses critical components of the experimental design for commutability assessment, including selection of individual CSs, use of pooled CSs, qualification of MPs for inclusion, establishing criteria for the determination that an RM is commutable, generalization of commutability conclusions to future measurements made with the MPs included in the assessment, and information regarding commutability to be included in the certificate for an RM. Parts 2 and 3 in the series present 2 different statistical approaches to commutability assessment that use fixed criteria related to the medical decisions that will be made using the laboratory test results.

UR - http://www.scopus.com/inward/record.url?scp=85042720866&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85042720866&partnerID=8YFLogxK

U2 - 10.1373/clinchem.2017.277525

DO - 10.1373/clinchem.2017.277525

M3 - Article

AN - SCOPUS:85042720866

VL - 64

SP - 447

EP - 454

JO - Clinical Chemistry

JF - Clinical Chemistry

SN - 0009-9147

IS - 3

ER -